1 ML meloxicam 30 MG/ML Injection [Qamzova] — RxCUI 2727445
RxNorm drug concept · Semantic branded drug
RxCUI 2727445
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2727445
Official name1 ML meloxicam 30 MG/ML Injection [Qamzova]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asQamzova 30 MG per 1 ML Injection; QAMZOVA 30 MG in 1 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Meloxicam: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Meloxicam treats pain and inflammation from osteoarthritis and rheumatoid arthritis in adults. It's also approved for juvenile rheumatoid arthritis in children — the oral suspensio...
- What conditions is meloxicam actually used to treat?
- Good news — you can take meloxicam with or without food, so whatever is easiest for you works fine. Taking it with a small snack can help if you find it bothers your stomach. It's...
- Can I take meloxicam with food, and does it matter what time of day I take it?
🕸️ Concept Web — How 1 ML meloxicam 30 MG/ML Injection [Qamzova] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
1 ML meloxicam 30 MG/ML Injection [Qamzova]
RxCUI 2727445 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Meloxicam
41493IN
-
Meloxicam
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Qamzova
2727441BN
-
Qamzova
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Meloxicam Injection
2281105SCDF -
Meloxicam Injectable Product
1165106SCDG -
Meloxicam Injection [Qamzova]
2727444SBDF -
Qamzova Injectable Product
2727443SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Meloxicam Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
1 ML meloxicam 30 MG/ML Injection
2281106SCD -
Meloxicam 30 MG/ML
2281104SCDC -
Meloxicam 30 MG/ML [Qamzova]
2727442SBDC
-
1 ML meloxicam 30 MG/ML Injection
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
1 ML meloxicam 30 MG/ML Injection
SCD · 2281106 -
Meloxicam 30 MG/ML
SCDC · 2281104 -
Meloxicam Injection
SCDF · 2281105 -
Meloxicam Injectable Product
SCDG · 1165106
Brand-Name Concepts
-
Meloxicam 30 MG/ML [Qamzova]
SBDC · 2727442 -
Meloxicam Injection [Qamzova]
SBDF · 2727444 -
Qamzova Injectable Product
SBDG · 2727443 -
Qamzova
BN · 2727441
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2727445 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 82972-0001-30 | 1 VIAL, SINGLE-DOSE in 1 CARTON (82972-001-30) / 1 mL in 1... | QAMZOVA | Nanjing Delova Biotech Co., Ltd. | 2025-10-15 |
Observed labelers:
Nanjing Delova Biotech Co., Ltd. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.